FemCare brand Healthfab acquires 2 acres land in Andhra Pradhesh to launch 2nd manufacturing facility for period care range of products; to invest Rs 15 crore

▴ FemCare brand Healthfab has announced signing of MoU with the Andhra Pradesh Govt
FemCare brand Healthfab has announced signing of MoU with the Andhra Pradesh Govt to acquire 2 acres of land in Kuppam, Chittoor District to launch their second manufacturing plant for a range of period care panties.

Bangalore 29th July 2026: FemCare brand Healthfab has announced signing of MoU with the Andhra Pradesh Govt to acquire 2 acres of land in Kuppam, Chittoor District to launch their second manufacturing plant for a range of period care panties. The Company plans to invest Rs 15 crore in the unit with an aim to generate over 700 direct and indirect employment. The expenditure will be spread across factory infrastructure, advanced manufacturing equipment, modern technology, quality assurance infrastructure and workforce development

The proposed manufacturing plant will house Healthfab's vertically integrated manufacturing facility, including production units, quality testing, warehousing, research & development and administrative infrastructure. With a monthly capacity of over 4 lakh period care panties, the company also plans to design and manufacture reusable period panties, disposable period panties and other products that are currently in the pipeline.

Commenting on the signing of MoU, Kiriti Acharjee, Co-founder, CEO, Healthfab said, “This will be our second manufacturing facility with the first one being at Bangalore. As we build this unit, we will focus on sustainability being an important pillar in the overall design and development. The facility is being planned with energy-efficient machinery, responsible waste management and recycling practices, water conservation measures, reduced manufacturing waste through optimized production, and environmentally responsible sourcing and packaging.”

We want to continue to strengthen quality control, innovation, production capacity, supply chain efficiency, and support the company's long-term growth plans, he added.

Healthfab recently raised Rs 20 crore in Series A round led by Atomic Capital. The company is on a trajectory to reach an ARR of INR 100 Crores within the next 100 days. Healthfab is backed by Mistry Ventures and Beyondseed of Singapore.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Rare Chest Wall Reconstruction at SRM Global Hospital Saves Critically Injured Road Accident VictimJuly 30, 2026
52-Year-Old Male with just 10% Heart Function successfully revived at Fortis Greater Noida via High-Risk Emergency AngioplastyJuly 30, 2026
Yashoda Hospitals Hitec City Achieves Landmark Milestone of 400+ Renal Transplants in less than 4 YearsJuly 30, 2026
Prostate Health Awareness: What Every Indian Man Must Know About Early Detection and PreventionJuly 30, 2026
Why Young Indians Are Facing Heart Problems: Causes, Warning Signs, and What to DoJuly 30, 2026
FemCare brand Healthfab acquires 2 acres land in Andhra Pradhesh to launch 2nd manufacturing facility for period care range of products; to invest Rs 15 crore July 29, 2026
Geriatric Wellness: New Technologies for Aging in Place GracefullyJuly 29, 2026
Digital Eye Strain 2.0: Protecting Vision in the Era of Spatial ComputingJuly 29, 2026
Endometriosis Awareness in India: Understanding the Condition That Affects Millions of Women in SilenceJuly 29, 2026
Prediabetes: Understanding the Critical Warning Stage Before DiabetesJuly 29, 2026
The Role of Microbiome in Pediatric Health: A New Era of Child WellnessJuly 28, 2026
The Rise of Bio-Individualized Diets: Tailoring Nutrition to Your DNAJuly 28, 2026
Immuneel Therapeutics and THSTI Announce Strategic Partnership to Advance CAR-T Cell Therapy and Lentiviral Vector Manufacturing July 28, 2026
Differential Diagnosis of Acute Abdomen: Differentiating Surgical Emergencies from Gastrointestinal MimicsJuly 28, 2026
Management of Rheumatic Heart Disease in Developing Nations: Secondary Prophylaxis and Valve InterventionsJuly 28, 2026
Hormonal Imbalance in Women: Understanding the Causes, Recognising the Symptoms, and Finding the Right TreatmentJuly 28, 2026
Why Regular Health Screening Matters: A Complete Guide for IndiansJuly 28, 2026
Galderma introduces Sculptra® in India, ushering in a new era of regenerative aestheticsJuly 27, 2026
Artificial Intelligence in Diagnostic Imaging: Enhancing Radiologist Precision and Reducing Human ErrorJuly 27, 2026
Transitioning from Acute Care to Urgent Care Centers: Optimizing Healthcare Facility InfrastructureJuly 27, 2026